EQX EBITDA
$1.46BTTM · USD
Period ending:
EQX FY EBITDAUSD
$948.08M-$26.31M
2007-03-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
EQX ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 19 observations from Mar 31, 2007 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 842,668,574 | |
| 948,078,000 | |
| 291,090,000 | |
| 130,782,000 | |
| 774,720,000 | |
| 222,461,131 | |
| 44,389,690 | |
| -26,312,166 | |
| -6,468,552 | |
| -2,156,000 | |
| -4,818,728 | |
| -3,741,465 | |
| -1,459,800 | |
| -395,778 | |
| -87,936 | |
| -95,461 | |
| -311,603 | |
| -47,914 | |
| -9,033 |
Compare ebitda
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) ebitda
- HSBC Holdings, plc. Common Stock (HSBC) ebitda
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) ebitda
- Novartis AG Common Stock (NVS) ebitda
- Royal Bank Of Canada Common Stock (RY) ebitda
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) ebitda
- SAP SE ADS (SAP) ebitda
- AstraZeneca PLC Ordinary Shares (AZN) ebitda
All EQX financial metrics · EQX stock overview · How to interpret financial metrics
